Cryoport

CYRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$889.905 M

$17.57 -0.28%

Close of 22 Sept 2026

Revenue

$176.2M

#2331 by revenue

Earnings

$78.3M

#1400 by earnings

Shares outstanding

50,649,100

Latest filing cover page

P/E ratio

11.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#163Rigel PharmaceuticalsRIGL$912.0M
#164ArdelyxARDX$902.1M
#165CryoportCYRX$889.9M
#166Avalo TherapeuticsAVTX$885.4M
#167Theravance BiopharmaTBPH$884.2M

What if Cryoport were worth as much as…

Open the what-if tool →

Gold $30.2T

$596,930.05

Per share 33,974× higher

Bitcoin $1.74T

$34,386.69

Per share 1,957× higher

Nvidia $5.52T

$108,901.58

Per share 6,198× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Cryoport are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.